We are live on ! Find out more
DA

DCF Advisers Portfolio holdings

AUM $375M
1-Year Est. Return 72.65%
This Fund
S&P 500
This Quarter Est. Return
+7.16%
1 Year Est. Return
+72.65%
3 Year Est. Return
+156.29%
5 Year Est. Return
+218.72%
10 Year Est. Return
AUM
$230M
AUM Growth
-$12.3M
Cap. Flow
-$21.2M
Cap. Flow %
-9.21%
Top 10 Hldgs %
41.59%
Holding
122
New
32
Increased
19
Reduced
29
Closed
19

Top Buys

Rank Stock Value
1
VZ icon
Verizon
VZ
+$2.41M
2
GM icon
General Motors
GM
+$2.39M
3
ABBV icon
AbbVie
ABBV
+$2.25M
4
CVS icon
CVS Health
CVS
+$1.57M
5
LLY icon
Eli Lilly
LLY
+$1.03M

Sector Composition

Rank Sector Weight
1 Healthcare 35.26%
2 Technology 14.96%
3 Communication Services 9.7%
4 Financials 5.34%
5 Consumer Discretionary 4.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ITCI
1
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$14.4M 6.26%
424,500
MU icon
2
Micron Technology
MU
$930B
$14.1M 6.14%
160,000
GOOG icon
3
Alphabet (Google) Class C
GOOG
$4.36T
$13.4M 5.84%
130,000
-5,000
-4% -$496K
ABBV icon
4
AbbVie
ABBV
$443B
$11M 4.8%
102,000
+21,000
+26% +$2.25M
XNCR icon
5
Xencor
XNCR
$1.5B
$8.18M 3.56%
190,000
-9,750
-5% -$462K
ORCL icon
6
Oracle
ORCL
$374B
$7.37M 3.2%
105,000
+13,000
+14% +$842K
QQQ icon
7
PUT
Invesco QQQ Trust
QQQ
$453B
$7.34M 3.19%
+23,000
New +$7.35M
GLD icon
8
SPDR Gold Trust
GLD
$131B
$6.8M 2.95%
42,500
-18,500
-30% -$3.11M
ARGX icon
9
argenx
ARGX
$54.6B
$6.61M 2.87%
24,000
REGN icon
10
Regeneron Pharmaceuticals
REGN
$78.5B
$6.39M 2.78%
13,500
+1,100
+9% +$536K
TPB icon
11
Turning Point Brands
TPB
$1.45B
$6.38M 2.77%
122,250
-2,500
-2% -$125K
BAC icon
12
Bank of America
BAC
$435B
$5.8M 2.52%
150,000
-17,500
-10% -$604K
GM icon
13
General Motors
GM
$80.4B
$5.75M 2.5%
100,000
+45,000
+82% +$2.39M
INCY icon
14
Incyte
INCY
$24.2B
$5.28M 2.3%
65,000
+2,500
+4% +$213K
IBB icon
15
PUT
iShares Biotechnology ETF
IBB
$9.34B
$5.27M 2.29%
+35,000
New +$5.56M
VZ icon
16
Verizon
VZ
$195B
$5.09M 2.21%
87,500
+42,750
+96% +$2.41M
C icon
17
Citigroup
C
$222B
$4.73M 2.06%
65,000
-5,000
-7% -$334K
AMD icon
18
Advanced Micro Devices
AMD
$776B
$4.32M 1.88%
55,000
GDX icon
19
VanEck Gold Miners ETF
GDX
$22.7B
$4.14M 1.8%
127,500
+7,500
+6% +$256K
T icon
20
AT&T
T
$159B
$3.78M 1.64%
165,500
-13,240
-7% -$293K
MU icon
21
PUT
Micron Technology
MU
$930B
$3.75M 1.63%
+42,500
New +$3.61M
IAU icon
22
iShares Gold Trust
IAU
$62.9B
$3.25M 1.41%
100,000
QQQ icon
23
CALL
Invesco QQQ Trust
QQQ
$453B
$3.19M 1.39%
+10,000
New +$3.2M
ALNY icon
24
Alnylam Pharmaceuticals
ALNY
$27.5B
$2.82M 1.23%
20,000
AMGN icon
25
Amgen
AMGN
$208B
$2.8M 1.22%
11,250

Similar funds

DCF Advisers's Q1 2021 Portfolio in Review

As of Q1 2021, DCF Advisers held 122 positions worth $230M, down 5.1% from $242M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

DCF Advisers withdrew a net $21.2M in Q1 2021, closing 19 positions and reducing 29 holdings. Its most notable exit was Intel, an estimated $2.44M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 32% a quarter earlier, followed by Technology and Communication Services.

Against the trend, DCF Advisers opened a new position in CVS Health worth $1.62M.

  • DCF Advisers's largest Q1 2021 buy was CVS Health: 21,500 shares worth $1.62M.
  • DCF Advisers added most to Verizon in Q1 2021, an estimated $2.41M increase.
  • DCF Advisers's biggest Q1 2021 reduction was SPDR Gold Trust, cutting an estimated $3.11M.
  • DCF Advisers fully exited Intel in Q1 2021, selling an estimated $2.44M.
  • DCF Advisers's ten largest holdings make up 42% of its $230M portfolio in Q1 2021.
  • DCF Advisers opened 32 new positions and closed 19 in Q1 2021.
  • DCF Advisers's portfolio value fell 5.1% quarter-over-quarter to $230M.

Based on DCF Advisers's 13F filing for Q1 2021, filed 12 May 2021.